Skip to main content
. 2019 Jul 26;46:150–159. doi: 10.1016/j.ebiom.2019.07.046

Fig. 3.

Fig. 3

mPS precisely stratifies prognosis of breast cancer patients. (a) Kaplan-Meier curves of OS according to mPS for the METABRIC test cohort. (b) Kaplan-Meier curves of OS according to PAM50 classification for the METABRIC test cohort. We omitted one patient whose PAM50 classification was not available. (c) Kaplan-Meier curves of OS for the METABRIC test cohort according to Integrative Cluster, which was proposed by the provider of the METABRIC data set. (d) Kaplan-Meier curves of OS according to mPS for the public data set GSE86166. (e) Kaplan-Meier curves of OS for the GSE86166 data set according to the 12-chemokine gene expression score proposed by the provider of the data set. (f) Kaplan-Meier curves of OS according to mPS for the public data set GSE96058.